Nitrous Oxide/Oxygen Mixture as Adjunct to Morphine May Provide Relief From Breakthrough Cancer PainJanuary 22, 2018
Self-administration of a nitrous oxide/oxygen mixture may be more effective than oxygen alone as an adjunct analgesic treatment in reducing moderate to severe breakthrough cancer pain.
Drug delivery with an intrathecal bolus is safe for the treatment and management of unpredictable breakthrough pain.
Fentanyl sublingual tablets are preferred over subcutaneous morphine in patients with severe breakthrough cancer pain.
Clinical Pain Advisor Articles
- Non-Opioid Therapies for Pain Management in the ED
- CBT vs Pain Education for Chronic Pain in Low-Income Clinics
- Betel Quid Addiction and Implications for Substance Use Disorder
- Factors Predicting Pain Outcomes After TKR for Knee Osteoarthritis
- Peripherally Acting Opioid and Cannabinoid May Be Effective for Neuropathic Pain
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- Once-Monthly Erenumab Injections May Be Effective for Episodic Migraine Prophylaxis
- The Pros and Cons of Direct-to-Consumer Genetic Testing
- Predicting Best Outcomes of Intra-Articular Hyaluronic Acid Treatment in Knee OA
- Virtual Reality as a Distraction From Pain During Medical Procedures
- Low Back Pain: Contributing Factors, Prophylactic Strategies, and Effective Treatments